A physician is reviewing promotional materials and abstracts for several newly approved medications. To accurately evaluate these clinical claims, the physician must understand fundamental biostatistical terminology. Match the following biostatistical terms to their corresponding clinical trial excerpts or definitions commonly found in drug advertisements.
- Absolute Risk Reduction (ARR)"The medication decreased the overall incidence of stroke by 4 percentage points compared to the placebo group."
- Number Needed to Treat (NNT)"Physicians must prescribe this therapy to 25 patients to prevent one additional adverse cardiovascular event."
- Relative Risk Reduction (RRR)"Patients taking the intervention experienced a 30% lower risk of disease progression relative to the control group."
- Surrogate Endpoint"The drug significantly reduced HbA1c levels, though data on long-term microvascular complications is pending."
Cevap
ARR matches the raw percentage point decrease; NNT matches the number of patients treated to prevent one event; RRR matches the proportional decrease relative to the control; Surrogate Endpoint matches the use of a biomarker (HbA1c) instead of a clinical complication.
Accurate interpretation of drug advertisements requires distinguishing between different measures of effect. Absolute Risk Reduction (ARR) shows the actual difference in event rates. Number Needed to Treat (NNT), derived from ARR, provides a practical clinical metric of effort to benefit. Relative Risk Reduction (RRR) shows proportional change and can inflate perceived benefit. Surrogate endpoints are laboratory or physiologic measures used as substitutes for direct clinical outcomes.
Adım Adım Çözüm
Anahtar Kavram
Understanding and identifying fundamental biostatistical terms (ARR, RRR, NNT, surrogate endpoints) used in medical literature and drug advertisements.